Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Müller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, García-Arencíbia M, Fernández-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, Rüb U, Chen A, Nussbaum RL, Auburger G. · 2009

Read Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. by Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Müller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, García-Arencíbia M, Fernández-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, Rüb U, Chen A, Nussbaum RL, Auburger G. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2686165.txt.

Introduction

Gispert and a large team studied in 2009 aged mice missing PINK1, a mitochondria protein whose loss causes an inherited form of Parkinson disease in people. They bred the knockout mice and watched them into old age, looking for the movement disorder's signs.

Old mice without PINK1 moved less in spontaneous activity and lost weight progressively, echoing the human illness. Dopamine, the brain chemical that fails in Parkinson disease, ran abnormal in the key pathway. Yet the expected cell death did not appear: no neurons died in that pathway, and no Lewy bodies, the protein clumps of the human disease, formed. Life span was normal too. Inside the cells, though, mitochondria failed step by step. Their protein imports slowed, and their energy making and breathing weakened. Only under stress did the organelles clump oddly. The model, the authors say, captures Parkinson disease's slow power failure without the final cell death.

Catalog record

CREATORGispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, Voos W, Leuner K, Müller WE, Kudin AP, Kunz WS, Zimmermann A, Roeper J, Wenzel D, Jendrach M, García-Arencíbia M, Fernández-Ruiz J, Huber L, Rohrer H, Barrera M, Reichert AS, Rüb U, Chen A, Nussbaum RL, Auburger G.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
LICENSECC0 1.0 Universal
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2686165

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration By Suzana Gispert, Filomena Ricciardi, Alexander Kurz, Mekhman Azizov, Hans-Hermann Hoepken, Dorothea Becker, Wolfgang Voos, Kristina Leuner, Walter E. Müller, Alexei P. Kudin, Wolfram S. Kunz, Annabelle Zimmermann Published in: PLoS ONE DOI: 10.1371/journal.pone.0005777 ABSTRACT Background Parkinson's disease (PD) is an adult-onset movement disorder of largely unknown etiology. We have previously shown that loss-of-function mutations of the mitochondrial protein kinase PINK1 (PTEN induced putative kinase 1) cause the recessive PARK6 variant of PD. Methodology/Principal Findings Now we generated a PINK1 deficient mouse and observed several novel phenotypes: A progressive reduction of weight and of locomotor activity selectively for spontaneous movements occurred at old age. As in PD, abnormal dopamine levels in the aged nigrostriatal projection accompanied the reduced movements. Possibly in line with the PARK6 syndrome but in contrast to sporadic PD, a reduced lifespan, dysfunction of brainstem and sympathetic nerves, visible aggregates of α-synuclein within Lewy bodies or nigrostriatal neurodegeneration were not present in aged PINK1-deficient mice. However, we demonstrate PINK1 mutant mice to exhibit a progressive reduction in mitochondrial preprotein import correlating with defects of core mitochondrial functions like ATP-generation and respiration. In contrast to the strong effect of PINK1 on mitochondrial dynamics in Drosophila melanogaster and in spite of reduced expression of fission factor Mtp18, we show reduced fission and increased aggregation of mitochondria only under stress in PINK1-deficient mouse neurons. Conclusion Thus, aging Pink1−/− mice show increasing mitochondrial dysfunction resulting in impaired neural activity similar to PD, in absence of overt neuronal death. INTRODUCTION Parkinson's disease (PD) is diagnosed mostly in elderly people by clinical criteria, based on a typical progressive reduction of their spontaneous movement activity in spite of preserved strength and coordination. The clinical deficits reflect progressive neurodegeneration, with initial unspecific symptoms due to pathology in the peripheral autonomic nervous system and in brainstem structures such as the dorsal motor vagal nucleus and the noradrenergic locus coeruleus neurons, and with a later typical movement deficit due to pathology of the dopaminergic neurons projecting from the midbrain substantia nigra to the striatum. Upon autopsy, the diagnostic hallmark of PD is the presence of cytosolic protein aggregates containing α-synuclein within the affected neurons (Lewy bodies). Damage by oxidative stress and mitochondrial dysfunction is documented for affected brain areas, but the molecular events underlying the pathogenesis are unknown. Several neurotoxins and disease genes may cause variants of PD differing in age of onset, manifestations and prognosis, but a common pathway has remained elusive and a routine laboratory diagnosis cannot yet be provided to patients. A clear genetic link between mitochondria and PD was defined by our identification of loss-of-function mutations in the mitochondrial protein PINK1 as the cause of autosomal recessive early-onset PARK6-linked Parkinsonism, a variant of PD with particularly early onset and mild progression that affects the autonomic and cognitive nervous system less than sporadic PD [1], [2]. PINK1 is a ubiquitously expressed 581 amino-acid protein with a serine-threonine kinase domain and a mitochondrial signal peptide [3]. In skin fibroblasts of 3 PARK6 patients with homozygosity for the G309D-PINK1 mutation, we could demonstrate an impaired activity of the respiratory complex I, an induction of antioxidant defence enzymes and enhanced lipid peroxidation [4], as well as altered α-synuclein mRNA levels [5]. Recombinant PINK1 can protect from apoptosis, modulate the mitochondrial membrane potential [1], localize to mitochondrial cristae [6] and was reported to phosphorylate the mitochondrial chaperone TRAP1 [7] and the mitochondrial protease HTRA2 [8]. In Drosophila melanogaster, PINK1 deficiency leads to fragmented mitochondrial cristae, hypersensitivity to oxidative stress, muscle and neuronal degeneration [9], [10] and is rescued by overexpression of parkin and fission factors DRP1 or FIS1, suggesting a physiological role of PINK1 in the dynamics or degradation of mitochondria [11], [12], [13]. Previous studies of Pink1 knock-out (KO) mouse brain reported (1) elevated susceptibility to H2O2 or heat-shock with decreased activities of the oxidative-stress vulnerable respiratory complexes as well as aconitase [14], (2) increased calcium levels and vulnerability with subsequent excess ROS production, decreased glucose availability and loss of mitochondrial membrane potential to cause pathological opening of the mitochondrial permeability transition pore [15], (3) reduced synaptic dopamine release and plasticity in the striatum [16], (4) sensitization to activation of group II metabotropic glutamate receptors at corticostriatal synapses [17] and (5) reduced viability of cortical neuron cultures [18]. It remained unclear, however, whether essential mitochondrial functions such as preprotein import and fission/fusion are maintained in the mice, whether the mitochondrial and synaptic dysfunction progress with age to impair movement and behaviour and whether a neurodegenerative process with α-synuclein aggregation is initiated. Since PARK6 is a rare PD variant and patient brain autopsies are still unavailable, the pathological features of PARK6 tissue remain undefined. To further elucidate the physiological role of PINK1 in mammalian tissue and to gain insight in the disease mechanisms of PARK6, we generated a PINK1 deficient mouse and assessed degrees of mitochondrial dysfunction at old age and the consequences for growth, motor performance, neuronal activity and aggregation/degeneration. RESULTS Generation of PINK1 deficient mice The pathogenic G309D-PINK1 mutation of our PARK6 patients was inserted into the orthologous mouse locus, using a neomycin (Neo) selection marker, flanked by loxP sites, engineered in intron V (Fig. 1A). The targeting vector was designed to allow a substitution of the G309D mutation, with minimal disruption of the Pink1 gene. Homologous recombination in embryonal stem cells was demonstrated by Southern blotting with an outside probe (Fig. 1B) and presence of the mutation in tail DNA by PCR amplification and restriction (Fig 1C). However, Northern blots with a probe covering Pink1 exons III to VI demonstrated no full-length Pink1 expression in the mice carrying this allele (Fig. 1D), suggesting interference with gene expression by the presence of Neo. The expression levels of the mutant Pink1 mRNA were reduced by a factor of 14 when analyzed by the Affymetrix transcriptome microarray and by a factor of 35 in quantitative real time RT-PCR (qPCR). To assess whether the intense smaller band detected by Northern blot represents a Pink1 isoform, qPCR analysis of Pink1 mRNA sequences on both sides of the Neo insertion site were performed and showed a 97% reduction in homozygous mutant brain tissue in both cases, indicating that the smaller band in Northern is due to unspecific cross-hybridization (Fig. 1E). Saturation reverse transcriptase (RT) PCR of each splicing boundary in brain and liver mRNA specifically detected normally spliced amplicons in wildtype (wt) and heterozygous (ht), but in homozygous tissues (hm) a smear of abnormally large amplification products was found for the exon 5–6 boundary suggesting the presence of intron 5 including the Neo selection marker (Fig. 1F). Additional saturation RT-PCR experiments confirmed the presence of Pink1 intron 5 and Neo sequences in the residual Pink1 mRNA and demonstrated the existence of smears of abnormally sized amplification fragments in homozygous tissue (Fig. 1G), suggesting that a Pink1 mRNA with excessive size is unstable and degraded to about 3% residual expression levels. Endogenous PINK1 protein cannot be detected reliably, probably due to very low expression levels [19]. Attempts to concentrate endogenous PINK1 protein through degradation inhibition and immunoprecipitation were promising in HEK293 but inconclusive in tissues, because

Read the complete text